Innovent Biologics, Inc.
General ticker "IVBXF" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $13.7B (TTM average)
Innovent Biologics, Inc. follows the US Stock Market performance with the rate: 40.3%.
Estimated limits based on current volatility of 2.0%: low 10.76$, high 11.21$
Short-term IVBXF quotes
Long-term IVBXF plot
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | CNY4,269.73MM | CNY4,556.38MM | CNY6,206.07MM |
| Operating Expenses | CNY6,973.08MM | CNY7,679.23MM | CNY7,885.37MM |
| Operating Income | CNY-2,703.35MM | CNY-3,122.85MM | CNY-1,679.30MM |
| Non-Operating Income | CNY61.63MM | CNY952.38MM | CNY534.89MM |
| Interest Expense | CNY62.46MM | CNY101.70MM | CNY98.62MM |
| R&D Expense | CNY2,478.07MM | CNY2,871.22MM | CNY2,227.56MM |
| Income(Loss) | CNY-2,641.72MM | CNY-2,170.47MM | CNY-1,144.41MM |
| Taxes | CNY87.04MM | CNY0.00MM | CNY0.00MM |
| Profit(Loss)* | CNY-2,728.76MM | CNY-2,179.27MM | CNY-1,027.91MM |
| Stockholders Equity | CNY10,330.40MM | CNY10,729.95MM | CNY12,527.58MM |
| Inventory | CNY1,347.24MM | CNY1,428.88MM | CNY968.09MM |
| Assets | CNY16,243.71MM | CNY17,588.85MM | CNY20,627.36MM |
| Operating Cash Flow | CNY-2,024.84MM | CNY-1,918.80MM | CNY147.81MM |
| Capital expenditure | CNY1,847.52MM | CNY1,381.73MM | CNY1,383.46MM |
| Investing Cash Flow | CNY-2,698.15MM | CNY-1,435.18MM | CNY-998.66MM |
| Financing Cash Flow | CNY5,003.36MM | CNY2,892.08MM | CNY2,587.26MM |
| Earnings Per Share** | CNY-1.88 | CNY-1.46 | CNY-0.66 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.